AXON — Axon Enterprise Income Statement
0.000.00%
Last trade - 00:00
- $22.16bn
- $21.51bn
- $1.56bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 531 | 681 | 863 | 1,190 | 1,563 |
Cost of Revenue | |||||
Gross Profit | 307 | 416 | 541 | 729 | 955 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 537 | 695 | 1,032 | 1,097 | 1,409 |
Operating Profit | -6.39 | -14.2 | -168 | 93.3 | 155 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2.07 | -6.29 | -141 | 197 | 155 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.882 | -1.72 | -60 | 147 | 174 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.882 | -1.72 | -60 | 147 | 174 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.882 | -1.72 | -60 | 147 | 174 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.015 | -0.018 | -0.907 | 2.03 | 2.25 |